Matthew Gline serves as Executive at Roivant Sciences Ltd., where they oversee executive responsibilities. Since joining the company, Matthew Gline has executed 62 insider transactions totaling $63.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 25, 2022 involved selling 19,276 shares valued at $84.8K.
Matthew Gline currently holds 17,287,081 shares of Roivant Sciences Ltd. (ROIV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Gline has been a net seller of ROIV stock. They have purchased $50.0K and sold $63.3M worth of shares.
Matthew Gline's most recent insider trade was on Oct 25, 2022, when they sold 19,276 shares at $4.40 per share.
Get notified when new Form 4 filings are submitted
| $3.07 |
| Discretionary |
| Aug 24, 2022 | ROIV | $74.2K | Sale | 20,009 | $3.71 | Discretionary |
| Jul 25, 2022 | ROIV | $88.6K | Sale | 20,455 | $4.33 | Discretionary |
| Jun 23, 2022 | ROIV | $86.2K | Sale | 19,855 | $4.34 | Discretionary |
| May 20, 2022 | ROIV | $517.2K | Sale | 139,791 | $3.70 | Discretionary |
| Apr 25, 2022 | ROIV | $32.7K | Sale | 8,509 | $3.84 | Discretionary |
| Mar 30, 2022 | ROIV | $163.0K | Sale | 33,686 | $4.84 | Discretionary |
| Mar 30, 2022 | ROIV | $119.7K | Payment | 25,254 | $4.74 | Discretionary |
| Mar 25, 2022 | ROIV | $179.1K | Sale | 35,386 | $5.06 | Discretionary |
| Mar 18, 2022 | ROIV | $420.7K | Sale | 82,006 | $5.13 | Discretionary |
| Mar 7, 2022 | ROIV | $509.6K | Sale | 92,324 | $5.52 | Discretionary |